Receptos Laboratories Private Limited - Company Profile

It is a business services private limited company based in Thane, Maharashtra, India, established in 2015.
2015 Thane, Maharashtra, India Struck Off
Last Updated:
About Receptos Laboratories Private Limited

Receptos Laboratories Private Limited, a struck off private limited company, was established on 28 January 2015 in Thane, Maharashtra, India. Engaging in other services within the business services sector, it holds CIN: U74999MH2015PTC261401. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a active non-compliant status. Its leadership includes Swaminathan Natarajan (Director), Ramaswamy Natarajan (Director). It is based at Flat No. A-301, Bldg No.4, Shree Padmavati Chs., Sai Section Ambernath (E),, Thane, Maharashtra, 421501.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2015PTC261401

  • Registration Number

    261401

  • Incorporation Date

    28 January 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 26 Days
Company report

Receptos Laboratories Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Receptos Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Receptos Laboratories Private Limited?
Current Directors
Name Designation Appointment Date Status
Swaminathan Natarajan Director 28 Jan 2015 Current
Ramaswamy Natarajan Director 28 Jan 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Receptos Laboratories.

Enhance accessibility to Receptos Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Receptos Laboratories revenue growth over time
Receptos Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Receptos Laboratories?

Unlock access to Receptos Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Receptos Laboratories?

Unlock and access historical data on people associated with Receptos Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Receptos Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Receptos Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Receptos Laboratories
Recent Activity within the Organization
  • Director Appointment

    Swaminathan Natarajan was appointed as a Director was appointed as a Director on 28 Jan 2015 & has been associated with this company since 11 years 26 days . was recorded as a recent event.

  • Director Appointment

    Ramaswamy Natarajan was appointed as a Director was appointed as a Director on 28 Jan 2015 & has been associated with this company since 11 years 26 days . was recorded as a recent event.

  • Company Incorporation

    The activity Receptos Laboratories Private Limited was registered on 28 Jan 2015 with Roc Mumbai & aged 11 years 26 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Receptos Laboratories Private Limited?

The CIN of Receptos Laboratories Private Limited is U74999MH2015PTC261401.

Where is Receptos Laboratories Private Limited headquartered?

Receptos Laboratories Private Limited is headquartered at Flat No. A-301, Bldg No.4, Shree Padmavati Chs., Sai Section Ambernath (E),, Thane, Maharashtra, 421501.

When was Receptos Laboratories Private Limited incorporated?

Receptos Laboratories Private Limited was incorporated on 28 January 2015.

Who are the current directors of Receptos Laboratories Private Limited?

The current directors of Receptos Laboratories Private Limited are

What is the primary industry of Receptos Laboratories Private Limited?

The primary industry of Receptos Laboratories Private Limited is Business Services.

Is Receptos Laboratories Private Limited a listed company?

Receptos Laboratories Private Limited is unlisted.

What is the capital structure of Receptos Laboratories Private Limited?

The authorized capital of Receptos Laboratories Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Receptos Laboratories Private Limited?

The compliance status of Receptos Laboratories Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available